AbbVie's Investigational, Pan-Genotypic Regimen of ABT-493 and ABT-530 Shows High SVR Rates in Genotype 1 Hepatitis C Patients Who Failed Previous Therapy with Direct-Acting Antivirals
95 percent of patients achieved SVR12 with 12 weeks of ABT-493 and ABT-530 with and without RBV in GT1 chronic HCV infected patients without cirrhosis who failed previous therapy with DAAs in a modified intent-to-treat analysis 91 percent achieved SVR12... BiopharmaceuticalsAbbVie, hepatitis C, MAGELLAN-1, ABT-493, ABT-530 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 15, 2016 Category: Pharmaceuticals Source Type: news

Antiviral therapy prolongs survival in immune tolerant hepatitis B patients
A new study demonstrates that the use of antiviral therapy for patients in the immune tolerant phase of hepatitis B (HBV) prolongs overall survival and reduces the risk of the most common form of liver cancer (Hepatocellular Carcinoma, HCC) and scarring of the liver (cirrhosis). (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 15, 2016 Category: Science Source Type: news

Antiviral therapy prolongs survival in immune tolerant hepatitis B patients
(European Association for the Study of the Liver) A new study, presented today at The International Liver Congress™ 2016 in Barcelona Spain, demonstrates that the use of antiviral therapy for patients in the immune tolerant phase of hepatitis B (HBV) prolongs overall survival and reduces the risk of the most common form of liver cancer (Hepatocellular Carcinoma, HCC) and scarring of the liver (cirrhosis). (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 15, 2016 Category: Infectious Diseases Source Type: news

Genetics Home Reference: cryptogenic cirrhosis
https://ghr.nlm.nih.gov/condition/cryptogenic-cirrhosis (Source: NLM General Announcements)
Source: NLM General Announcements - April 12, 2016 Category: Databases & Libraries Source Type: news

Beer has a surprisingly positive effect on reducing bone damage and women's chances for getting osteoporosis
(NaturalNews) There are plenty of reasons not to drink alcohol, we're told, but what if there were some good reasons to grab a beer from time to time?While consuming too much alcohol over a long period of time can exacerbate cirrhosis of the liver, having a cold brew occasionally... (Source: NaturalNews.com)
Source: NaturalNews.com - April 11, 2016 Category: Consumer Health News Source Type: news

FDA Advisory Committee Unanimously Recommends Accelerated Approval of Ocaliva (obeticholic acid) for the Treatment of Primary Biliary Cirrhosis
NEW YORK, April 07, 2016 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 11, 2016 Category: Drugs & Pharmacology Source Type: news

‘We have a chance to show the truth’: into the heart of Chernobyl
Three decades after the nuclear disaster, the concrete protecting the reactor is starting to crack. Yet people still live there – and a new virtual reality project will take many more inside the ‘death zone’At first they thought it was just a fire, then the chickens started to turn black. When it comes to the Chernobyl nuclear disaster, everyone has a vivid detail that is snagged in the memory; the absurdities or the obscenities. It might be the local village that, once evacuated, was claimed by a mob of pigs. Or the way milk would turn to white powder whenever the residents of Pripyat (the town built a f...
Source: Guardian Unlimited Science - April 9, 2016 Category: Science Authors: Simon Parkin Tags: Chernobyl nuclear disaster Nuclear power Virtual reality Technology Ukraine Europe World news Russia Energy Cancer Health Environment Society Source Type: news

Effects of an exercise programme on functional capacity, body composition and risk of falls in patients with cirrhosis: a randomized clinical trial - Román E, García-Galcerán C, Torrades T, Herrera S, Marín A, Doñate M, Alvarado-Tapias E, Malouf J, Nácher L, Serra-Grima R, Guarner C, Córdoba J, Soriano G.
UNLABELLED: Patients with cirrhosis often have functional limitations, decreased muscle mass, and a high risk of falls. These variables could improve with exercise. The aim was to study the effects of moderate exercise on functional capacity, body composit... (Source: SafetyLit)
Source: SafetyLit - April 2, 2016 Category: Global & Universal Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

New test can predict death in patients with serious liver disease
The biomarker CD163 can predict mortality in blood samples from patients with acute on chronic liver failure, report scientists. Acute-on-chronic liver failure (ACLF) is a sudden deterioration of the liver function in a patient with liver cirrhosis accompanied by failure of one or more organ systems. This liver disease has a serious prognosis and the four-week mortality rate is 20-30%. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 1, 2016 Category: Science Source Type: news

Cirrhosis Underrecognized in Hepatocellular Cancer PatientsCirrhosis Underrecognized in Hepatocellular Cancer Patients
Are clinicians properly screening their patients with cirrhosis for hepatocellular carcinoma, and how important is timely identification of disease? Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 1, 2016 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Simeprevir-Sofosbuvir for Chronic Hepatitis C With CirrhosisSimeprevir-Sofosbuvir for Chronic Hepatitis C With Cirrhosis
The combination of simeprevir (SMV) and sofosbuvir (SOF) is effective treatment for patients with chronic hepatitis C virus (HCV) genotype 1 infection and cirrhosis, according to results from OPTIMIST-2. Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 25, 2016 Category: Gastroenterology Tags: Infectious Diseases News Source Type: news

Antibiotics Side Effects on the Mitochondria
Science is just beginning to understand how important your mitochondria are to warding off the diseases of aging. And, as usual, mainstream medicine is lagging way behind. Along with your telomeres, the cellular time keepers at the ends of your chromosomes, your mitochondria are another key component of the anti-aging equation. You see, these tiny organelles in your cells are the power plants that turn fuel into energy for your body. Healthy mitochondria keep you young and energetic.  Research shows that damaged mitochondria can lead to: Schizophrenia and bipolar disorder; Alzheimer’s and Parkinson’s d...
Source: Al Sears, MD Natural Remedies - March 25, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Natural Cures Source Type: news

Coffee Consumption and the Risk of CirrhosisCoffee Consumption and the Risk of Cirrhosis
Are coffee drinkers at an increased risk of cirrhosis or does the opposite hold true? Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 25, 2016 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

5 Steps to Deal With a Chronic Illness
I was diagnosed with chronic hepatitis C in 1985, when it was still called non-A non-B. My doctor didn't sugar coat his words when he said to me: "Toni, I am sorry but there is no cure. You have a ticking time bomb inside and nobody can predict how long you have to live." My heart stopped and the course of my life was forever altered. For the next few years, I desperately tried every alternative medicine treatments and modalities to no avail. This virus is a formidable foe. It replicates itself at the speed of light and attacks healthy liver cells leading to fibrosis, cirrhosis and liver cancer. It is the leadin...
Source: Healthy Living - The Huffington Post - March 23, 2016 Category: Consumer Health News Source Type: news

Palliative Care for CirrhosisPalliative Care for Cirrhosis
How can clinicians best manage the end-of-life care needs of their patients with cirrhosis? Frontline Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 21, 2016 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Mitochondrial Function: The Other Half Of The Anti-Aging Story
Telomere science changed everything we knew about aging. But today, I want to talk to you about the other half of the anti-aging equation. Regular readers will already know by protecting your telomeres, you can slow — and even reverse — the aging process. You see, your telomeres are like little countdown clocks that protect the DNA in your cells. They shorten with each cell division. And the shorter they get the faster you develop the signs of aging. So by protecting and nourishing them, you can literally turn back the years. I was one of the first doctors to put telomere science to the test. And for years, I&...
Source: Al Sears, MD Natural Remedies - March 9, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Anti-Aging mitochondria telomere Source Type: news

Modified protein reverses cirrhosis in lab rats
A protein modified to increase the amount of time it circulates in the bloodstream appears to reverse liver fibrosis and cirrhosis in rats, according to results of a study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 3, 2016 Category: Science Source Type: news

Study shows broccoli may offer protection against liver cancer
(University of Illinois College of Agricultural, Consumer and Environmental Sciences) Research has shown that eating broccoli three to five times per week can lower the risk of many types of cancers. Consuming a high-fat, high-sugar diet and having excess body fat is linked with the development of nonalcoholic fatty liver disease (NAFLD), which can lead to diseases such as cirrhosis and liver cancer. A new study from the University of Illinois shows that including broccoli in the diet may protect against liver cancer, as well as aid in countering the development of NAFLD. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 3, 2016 Category: Global & Universal Source Type: news

Visceral Fat Triggers Heart Disease
I tell my patients to avoid drinking soda not just because they make you fat. Each sip of soda affects your health. Soda puts you at risk for health problems like metabolic syndrome. This is a collection of symptoms that can lead to diabetes, heart disease and other chronic diseases, like cancer. Soft drinks are the beverage of choice for millions of Americans. The latest research now reveals that sodas are a major cause of visceral fat — the deadliest kind of fat you can have, inflaming your tissues, rotting your blood vessels and upsetting your body chemistry. In a minute I’m going to tell you about a great ...
Source: Al Sears, MD Natural Remedies - February 29, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Heart Health heart disease metabolic syndrome Visceral Fat Source Type: news

Science proves these seven herbs provide powerful protection against liver cancer and liver damage of all kinds
(NaturalNews) More than 10 percent of the world's population currently suffers from some form of liver disease, whether it be fibrosis, cirrhosis, a hepatocellular carcinoma, alcoholic steatosis, or chronic hepatitis. And a great number of these folks use some kind of natural remedy... (Source: NaturalNews.com)
Source: NaturalNews.com - February 29, 2016 Category: Consumer Health News Source Type: news

Electronic program reduces cirrhosis readmission rates
An electronic quality improvement initiative for patients with cirrhosis has achieved significant reductions in 30-day readmission rates. The program’s goals included universal use of rifaximin and... (Source: Family Practice News)
Source: Family Practice News - February 25, 2016 Category: Primary Care Source Type: news

Primary biliary cirrhosis: case study
A case of primary biliary cirrhosis discovered during routine liver function tests, highlights the symptoms to look out for. (Source: GP Online Education)
Source: GP Online Education - February 25, 2016 Category: Primary Care Tags: 15.2 Digestive Problems Source Type: news

Predicting Liver Cirrhosis in Patients With Chronic HCVPredicting Liver Cirrhosis in Patients With Chronic HCV
How can clinicians best predict which patients with chronic hepatitis C are most likely to develop cirrhosis? Alimentary Pharmacology & Therapeutics (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 24, 2016 Category: Pathology Tags: Gastroenterology Journal Article Source Type: news

You Don't Need To Lose A Lot Of Weight To Start Seeing Health Benefits
This study clarifies conventional wisdom among obesity experts, who have traditionally advised patients to lose 5 to 10 percent of their body weight in order to improve blood pressure, cholesterol and blood sugar levels. But as anyone who has ever tried to lose weight can attest, there is a big difference between 5 percent and 10 percent.   "That’s a very vague, wide range," Klein said. "It’s much harder to achieve a 10 percent weight loss than it is to achieve a five percent weight loss." Klein said his study shows that even just a little bit of weight loss is enough to improve he...
Source: Science - The Huffington Post - February 23, 2016 Category: Science Source Type: news

Coffee May Protect Liver From Alcohol
New research examines the link between coffee and cirrhosis liver disease. (Source: U.S. News - Health)
Source: U.S. News - Health - February 22, 2016 Category: Consumer Health News Authors: Samantha Costa Source Type: news

Drinking two cups of coffee a day 'drastically reduces risk of liver cirrhosis', according to experts
Four cups a day could lower the risk by 65 per cent, researchers say (Source: Telegraph Health)
Source: Telegraph Health - February 22, 2016 Category: Consumer Health News Tags: coffee liver cirrhosis Source Type: news

Drinking more coffee may help prevent alcohol-related cirrhosis
Make that black coffee order a double. (Source: CNN.com - Health)
Source: CNN.com - Health - February 22, 2016 Category: Consumer Health News Source Type: news

Coffee may help prevent this liver disease
Make that black coffee order a double. Upping your coffee intake may help reduce your chances of developing alcohol-related cirrhosis, according to a review done by the journal Alimentary Pharmacology and Therapeutics of multiple existing studies. Dr... (Source: WDSU.com - Health)
Source: WDSU.com - Health - February 20, 2016 Category: Consumer Health News Source Type: news

Drinking Coffee Linked To Lower Rates Of Liver Cirrhosis
(Reuters Health) - Drinking more coffee might help reduce the kind of liver damage that's associated with overindulging in food and alcohol, a review of existing studies suggests. Researchers analyzed data from nine previously published studies with a total of more than 430,000 participants and found that drinking two additional cups of coffee a day was linked to a 44 percent lower risk of developing liver cirrhosis. "Cirrhosis is potentially fatal and there is no cure as such," said lead study author Dr. Oliver Kennedy of Southampton University in the U.K. "Therefore, it is significant that the risk of deve...
Source: Science - The Huffington Post - February 20, 2016 Category: Science Source Type: news

Drinking Coffee Linked To Lower Rates Of Liver Cirrhosis
(Reuters Health) - Drinking more coffee might help reduce the kind of liver damage that's associated with overindulging in food and alcohol, a review of existing studies suggests. Researchers analyzed data from nine previously published studies with a total of more than 430,000 participants and found that drinking two additional cups of coffee a day was linked to a 44 percent lower risk of developing liver cirrhosis. "Cirrhosis is potentially fatal and there is no cure as such," said lead study author Dr. Oliver Kennedy of Southampton University in the U.K. "Therefore, it is significant that the risk of deve...
Source: Healthy Living - The Huffington Post - February 20, 2016 Category: Consumer Health News Source Type: news

No, Coffee Does Not Reverse The Health Risks Of Alcohol
A new study finds that coffee drinkers have a reduced risk of cirrhosis. But this is not license to drink. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 19, 2016 Category: Pharmaceuticals Authors: Alice G. Walton Source Type: news

4 cups of coffee a day 'reduces risk of liver damage linked to drinking alcohol'
Scientists at the University of Southampton found drinking two additional cups of coffee a day was linked to a 44 per cent lower risk of developing liver cirrhosis, typically caused by excessive alcohol consumption. (Source: the Mail online | Health)
Source: the Mail online | Health - February 19, 2016 Category: Consumer Health News Source Type: news

FDA Expands Use of Liver Drug to Subset of PatientsFDA Expands Use of Liver Drug to Subset of Patients
The U.S. Food and Drug Administration has expanded the use of Gilead Sciences Inc's drug Harvoni (ledipasvir and sofosbuvir) to some hepatitis C patients in the advanced stage of cirrhosis, including those who have undergone liver transplant. FDA Approvals (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - February 17, 2016 Category: Gastroenterology Tags: Gastroenterology News Alert Source Type: news

FDA Expands Use of Gilead's Harvoni to Rare Subset of Patients
The pill has been expanded to some hepatitis C patients in the advanced stage of cirrhosis. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - February 16, 2016 Category: Pharmaceuticals Source Type: news

Aerobic fitness may protect liver against chronic alcohol use
Excessive alcohol use is responsible for more than 80,000 deaths in the United States each year. Over time, excessive drinking can lead to several chronic conditions, such as fatty liver disease and cirrhosis. Now, a study shows that aerobic exercise may protect the liver against alcohol-related inflammation and injury. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 16, 2016 Category: Science Source Type: news

Aerobic fitness may protect liver against chronic alcohol use
(University of Missouri-Columbia) According to the Centers for Disease Control and Prevention, excessive alcohol use is responsible for more than 80,000 deaths in the United States each year. Over time, excessive drinking can lead to several chronic conditions, such as fatty liver disease and cirrhosis. Now, a study by University of Missouri School of Medicine researchers shows that aerobic exercise may protect the liver against alcohol-related inflammation and injury. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 15, 2016 Category: Global & Universal Source Type: news

How Alcohol Use Affects Health
You may have heard of Dry January, a campaign run in the U.K. by Alcohol Concern. To promote alcohol awareness, it involves (as you’ve likely gathered) completely abstaining from alcohol for the month of January. It’s a valuable campaign with noble intentions, but a minority of participants may unfortunately miss the wider point. A month of strict abstinence does lead some to drink more than they should come February 1. Remaining alcohol free for a month is an achievement which deserves to be rewarded, but compensatory drinking is not what Dry January is trying to advocate. A healthy attitude towards consu...
Source: Psych Central - February 13, 2016 Category: Psychiatry Authors: Dr. Wayne Osborne Tags: Addictions Alcoholism General Healthy Living Substance Abuse Abstinence Alcohol Abuse Alcoholic beverage Binge Drinking Drinking culture Liver disease Liver health Long-term effects of alcohol Moderation National Council on Alc Source Type: news

FDA Expands Use of HCV Drug Daclatasvir (Daklinza)FDA Expands Use of HCV Drug Daclatasvir (Daklinza)
Updated label permits use of the drug for patients with HCV genotype 1 and 3 and HIV-1 coinfection, advanced cirrhosis, and HCV recurrence after liver transplant, the company says. Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - February 10, 2016 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Fast Forward begins two Phase II trials of FFP104 in PBC and Crohn’s disease patients
Fast Forward Pharmaceuticals has started two Phase II clinical trials of FFP104, a potential treatment for patients with primary biliary cirrhosis (PBC) and Crohn's disease. (Source: Drug Development Technology)
Source: Drug Development Technology - February 4, 2016 Category: Pharmaceuticals Source Type: news

Medical News Today: Coffee may protect against liver cirrhosis
A pooled analysis of data from studies published to date finds that increasing coffee consumption may substantially reduce the risk of liver cirrhosis. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 3, 2016 Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news

EC approves Daklinza for the treatment of chronic hepatitis C patients
Bristol-Myers Squibb Company announced that the European Commission has approved Daklinza for the treatment of chronic hepatitis C (HCV) in three new patient populations (Source: Pharmacy Europe)
Source: Pharmacy Europe - February 2, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Practical therapeutics Patient care ALLY-1 ALLY-2 cirrhosis CYP3A daklinza hcv hiv-1 Latest News P-glycoprotein transporter post-liver transplant Sofosbuvir Source Type: news

Monthly News Roundup - January 2016
Merck’s Once-Daily Zepatier for Hepatitis C Wins Approval Hepatitis C virus (HCV) affects over 3 millions Americans, and may lead to liver impairment, cirrhosis or even liver failure. In January, the U.S. Food and Drug Administration (FDA)... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 31, 2016 Category: Pharmaceuticals Source Type: news

Merck Receives FDA Approval of ZEPATIER(TM) (elbasvir and grazoprevir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 or 4 Infection in Adults Following Priority Review
ZEPATIER Achieves High Cure Rates (SVR12) in Broad Range of Patients with Chronic Hepatitis C Infection, Including Those with Compensated Cirrhosis, Renal Impairment of Any Degree and HIV-1/HCV Co-infection KENILWORTH, N.J., Jan. 28, 2016 -- (Healthcare... Biopharmaceuticals, FDA, Product LaunchMerck, ZEPATIER, elbasvir, grazoprevir, Hepatitis C Virus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 29, 2016 Category: Pharmaceuticals Source Type: news

Merck Receives FDA Approval of ZEPATIER™ (elbasvir and grazoprevir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 or 4 Infection in Adults Following Priority Review
Dateline City: KENILWORTH, N.J. ZEPATIER Achieves High Cure Rates (SVR12) in Broad Range of Patients with Chronic Hepatitis C Infection, Including Those with Compensated Cirrhosis, Renal Impairment of Any Degree and HIV-1/HCV Co-infection KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved ZEPATIER™ (elbasvir and grazoprevir) for the treatment of adult patients with chronic hepatitis C virus (HCV) ...
Source: Merck.com - Corporate News - January 29, 2016 Category: Pharmaceuticals Tags: Prescription Medicine News Corporate News Latest News #Merck #MRK $MRK Hepatitis NYSE:MRK Source Type: news

Merck Receives FDA Approval of ZEPATIER ™ (elbasvir and grazoprevir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 or 4 Infection in Adults Following Priority Review
Dateline City: KENILWORTH, N.J. ZEPATIER Achieves High Cure Rates (SVR12) in Broad Range of Patients with Chronic Hepatitis C Infection, Including Those with Compensated Cirrhosis, Renal Impairment of Any Degree and HIV-1/HCV Co-infection KENILWORTH, N.J.--( BUSINESS WIRE )--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved ZEPATIER ™ (elbasvir and grazoprevir) for the treatment of adult patients with chronic hepatitis C virus (HCV) genotype (GT) 1 or GT4 infection, with or w...
Source: Merck.com - Product News - January 29, 2016 Category: Drugs & Pharmacology Tags: Prescription Medicine News Corporate News Latest News #Merck #MRK $MRK Hepatitis NYSE:MRK Source Type: news

Relapsed Alcoholic? This Is for You
Hi, my name is Vivienne and my dead sister was an alcoholic. If you've fallen off the wagon (again), you don't want to hear about the latest alcohol health and safety statistics or the merits of various treatment programs -- you've probably heard all that before. I am here to give you FIVE messages of hope and encouragement to help you get back on the road to recovery as soon as possible. Five things I wish my sister had known before alcoholism killed her at 51 years old, two and a half years ago. First, let me tell you about Coral -- my bright, beautiful, fun-loving sister. Alcohol seduced Coral in her teens, charming he...
Source: Healthy Living - The Huffington Post - January 27, 2016 Category: Consumer Health News Source Type: news

New cures for hepatitis C — but are they affordable?
The public health burden of hepatitis C is enormous. This serious viral infection of the liver causes cirrhosis, liver cancer, and end-stage liver failure, often requiring liver transplantation. Over 3 million people in the United States, and 150 million worldwide, are infected with hepatitis C virus, resulting in 700,000 deaths per year. People who are infected with hepatitis C virus often have no symptoms. The virus persists in the liver, slowly damaging liver tissue over a long period of time. For this reason, it is critical that progression of liver damage be stopped before advanced liver disease or liver cancer occurs...
Source: New Harvard Health Information - January 7, 2016 Category: Consumer Health News Authors: Gregory Curfman, MD Tags: Drugs and Supplements Health Health care Infectious diseases hepatitis C Source Type: news

Combo Tx Benefits Biliary Cirrhosis Pts Failing Ursodeoxycholic Acid (CME/CE)
(MedPage Today) -- Adding bezafibrate boosts responses, meta-analysis suggests (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - December 27, 2015 Category: Gastroenterology Source Type: news

CDC finds US alcohol poisoning and cirrhosis 'deaths hit record high'
The Centers for Disease Control and Prevention revealed that more than 30,700 people in the US died in 2014 because of alcohol-induced causes - a 37 per cent increase from 2002. (Source: the Mail online | Health)
Source: the Mail online | Health - December 24, 2015 Category: Consumer Health News Source Type: news